| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.16 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |